Lipid regulation of the glucagon receptor family

被引:1
作者
Oqua, Affiong Ika [1 ]
Manchanda, Yusman [1 ]
Mcglone, Emma Rose [2 ]
Jones, Ben [3 ]
Rouse, Sarah [4 ]
Tomas, Alejandra [1 ]
机构
[1] Imperial Coll London, Sect Cell Biol & Funct Genom, Div Diabet Endocrinol & Diabet, Dept Metab Digest & Reprod, London, England
[2] Imperial Coll London, Dept Surg & Canc, London, England
[3] Imperial Coll London, Dept Metab Digest & Reprod, Div Diabet Endocrinol & Metab, Sect Endocrinol & Invest Med, London, England
[4] Imperial Coll, Dept Life Sci, London, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
lipid; glucagon receptor; GLP-1; receptor; GIP receptor; cholesterol; METABOTROPIC GLUTAMATE-RECEPTOR; CHOLESTEROL-BINDING-SITE; PROTEIN INTERACTIONS; CELL FUNCTION; FATTY-ACIDS; BETA-CELL; PEPTIDE-1; MEMBRANE; DYNAMICS; AGONIST;
D O I
10.1530/JOE-23-0335
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The glucagon receptor family are typical class B1 G protein-coupled receptors (GPCRs) with important roles in metabolism, including the control of pancreas, brain, and liver function. As proteins with seven transmembrane domains, GPCRs are intimately in contact with lipid bilayers and therefore can be putatively regulated by interactions with their lipidic components, including cholesterol, sphingolipids, and other lipid species. Additionally, these receptors, as well as the agonists they bind to, can undergo lipid modifications, which can influence their binding capacity and/or elicit modified or biased signalling profiles. While the effect of lipids, and in particular cholesterol, has been widely studied for other GPCR classes, information about their role in regulating the glucagon receptor family is only beginning to emerge. Here we summarise our current knowledge on the effects of cholesterol modulation of glucagon receptor family signalling and trafficking profiles, as well as existing evidence for specific lipid-receptor binding and indirect effects of lipids via lipid modification of cognate agonists. Finally, we discuss the different methodologies that can be employed to study lipid-receptor interactions and summarise the importance of this area of investigation to increase our understanding of the biology of this family of metabolically relevant receptors.
引用
收藏
页数:16
相关论文
共 157 条
[51]   Novel agonist and antagonist radioligands for the GLP-2 receptor. Useful tools for studies of basic GLP-2 receptor pharmacology [J].
Gadgaard, Sarina ;
van der Velden, Wijnand J. C. ;
Schiellerup, Sine P. ;
Hunt, Jenna Elizabeth ;
Gabe, Maria B. N. ;
Windelov, Johanne Agerlin ;
Boer, Geke Aline ;
Kissow, Hannelouise ;
Orskov, Cathrine ;
Holst, Jens J. ;
Hartmann, Bolette ;
Rosenkilde, Mette M. .
BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (09) :1998-2015
[52]   Glucagon Receptor Signaling and Lipid Metabolism [J].
Galsgaard, Katrine D. ;
Pedersen, Jens ;
Knop, Filip K. ;
Holst, Jens J. ;
Albrechtsen, Nicolai J. Wewer .
FRONTIERS IN PHYSIOLOGY, 2019, 10
[53]   Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity [J].
Gao, Wenwen ;
Liu, Lei ;
Huh, Eunna ;
Gbahou, Florence ;
Cecon, Erika ;
Oshima, Masaya ;
Houze, Ludivine ;
Katsonis, Panagiotis ;
Hegron, Alan ;
Fan, Zhiran ;
Hou, Guofei ;
Charpentier, Guillaume ;
Boissel, Mathilde ;
Derhourhi, Mehdi ;
Marre, Michel ;
Balkau, Beverley ;
Froguel, Philippe ;
Scharfmann, Raphael ;
Lichtarge, Olivier ;
Dam, Julie ;
Bonnefond, Amelie ;
Liu, Jianfeng ;
Jockers, Ralf .
NATURE METABOLISM, 2023, 5 (10) :1673-+
[54]   Clinical review 124 - Diabetic dyslipidemia: Causes and consequences [J].
Goldberg, IJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :965-971
[55]   Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model [J].
Gorden, D. Lee ;
Ivanova, Pavlina T. ;
Myers, David S. ;
McIntyre, J. Oliver ;
VanSaun, Michael N. ;
Wright, J. Kelly ;
Matrisian, Lynn M. ;
Brown, H. Alex .
PLOS ONE, 2011, 6 (08)
[56]   Postprandial dysfunction in fatty liver disease [J].
Grandt, Josephine ;
Jensen, Anne-Sofie H. ;
Werge, Mikkel P. ;
Rashu, Elias B. ;
Moller, Andreas ;
Junker, Anders E. ;
Hobolth, Lise ;
Mortensen, Christian ;
Johansen, Christian D. ;
Vyberg, Mogens ;
Serizawa, Reza Rafiolsadat ;
Moller, Soren ;
Gluud, Lise Lotte ;
Albrechtsen, Nicolai Wewer J. .
PHYSIOLOGICAL REPORTS, 2023, 11 (08)
[57]   Structure and mechanism of mitochondrial electron transport chain [J].
Guo, Runyu ;
Gu, Jinke ;
Zong, Shuai ;
Wu, Meng ;
Yang, Maojun .
BIOMEDICAL JOURNAL, 2018, 41 (01) :9-20
[58]   A specific cholesterol binding site is established by the 2.8 Å structure of the human β2-adrenergic receptor [J].
Hanson, Michael A. ;
Cherezov, Vadim ;
Griffith, Mark T. ;
Roth, Christopher B. ;
Jaakola, Veli-Pekka ;
Chien, Ellen Y. T. ;
Velasquez, Jeffrey ;
Kuhn, Peter ;
Stevens, Raymond C. .
STRUCTURE, 2008, 16 (06) :897-905
[59]   Understanding the diversity of membrane lipid composition [J].
Harayama, Takeshi ;
Riezman, Howard .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2018, 19 (05) :281-296
[60]   Cholesterol Interaction Sites on the Transmembrane Domain of the Hedgehog Signal Transducer and Class F G Protein-Coupled Receptor Smoothened [J].
Hedger, George ;
Koldso, Heidi ;
Chavent, Matthieu ;
Siebold, Christian ;
Rohatgi, Rajat ;
Sansom, Mark S. P. .
STRUCTURE, 2019, 27 (03) :549-+